Point-of-Care Pathogen Detection with CRISPR-based Programmable Nucleic Acid Binding Proteins

Area of Science:

• Molecular Biology
• Genomics
• Biotechnology

Background:

• Engineered nucleic acid-binding proteins, particularly CRISPR-Cas systems, have revolutionized genome editing and molecular diagnostics.
• The discovery of adaptive immunity in prokaryotes via CRISPR-Cas has driven significant advances in molecular biology.
• CRISPR-Cas biology is expanding visions in molecular diagnostics for pathogen identification, SNP analysis, and cell-free mutation detection.

Purpose of the Study:

• To review the fundamental features of CRISPR/Cas-based molecular diagnostic technologies.
• To summarize the potential applications of CRISPR-Cas systems in point-of-care (POC) pathogen detection.
• To highlight recent advances enhancing multiplexing, quantification, and instrument-free nucleic acid detection.

Main Methods:

• Review of current literature on CRISPR-Cas systems and their diagnostic applications.
• Analysis of technological advancements in CRISPR-Cas based detection methods.
• Exploration of emerging applications in microbiological diagnostics and POC settings.

Main Results:

• CRISPR-Cas technologies provide programmable nucleic acid-binding capabilities for revolutionizing diagnostic platforms.
• Advances enable identification of DNA/RNA in pathogens, SNP detection, and cell-free mutation analysis.
• Improvements in multiplexing, quantification, and instrument-free detection are paving the way for POC diagnostics.

Conclusions:

• CRISPR-Cas based molecular diagnostics represent a significant leap forward in identifying microbiological pathogens.
• These technologies hold immense potential for rapid, accurate detection of bacteria and viruses at the point of care.
• The ongoing evolution of CRISPR-Cas systems promises to further enhance diagnostic capabilities in diverse settings.